Part of the Common Fund's High-Risk, High-Reward Program, the Transformative Research Award supports exceptionally innovative, unconventional, paradigm-shifting research projects that are inherently risky and untested.
Helen Blau, a 2012 awardee, developed a new technique for rapidly extending telomeres by delivering non-immunogenic modified mRNA encoding the telomerase protein TERT. The method is safe with no risk of genomic insertion and provides a crucial tool for research on extending telomeres to increase lifespans.
Breakthrough Technique Expands the Capabilities of Microscopes
Dr. Edward Boyden (New Innovator, Pioneer, and Transformative Research Awardee) has developed a novel microscopy technique allowing high resolution imaging by enlarging the sample with material found in baby diapers in a method called expansion microscopy. Boyden is able to expand tissues to 4.5 times their normal size, enabling visualization of tiny cellular structures and proteins with ordinary microscopes.
Discovering New Antibiotics
Dr. Kim Lewis, a 2009 awardee, used newly developed technology to discover 25 new antibiotics, including teixobactin. Teixobactin kills pathogens without encountering any detectable resistance and holds promise for treating an array of difficult to treat human infections like staphylococcus aureus (aka MRSA) and tuberculosis.
|• Open to individuals or teams at all career stages
• No limits on budget requests
• Find IC-specific guidelines for Clinical Research
• Find an IC host for Scientific Research
• More information
|FY 2015||Applications Under Review|
Due October 9, 2015
|Karl Deisseroth (2005 Pioneer and 2012 Transformative Researcher) receives the FNIH 2015 Lurie Prize for his work on optogenetics. Dr. Desisseroth also received the Carnegie Mellon's Dickson Prize in Science and the 2014 Keio Medical Science Prize for his revolutionary work in optogenetics and his work on CLARITY, converting tissue into a gel linked to polymers that allow transparency and high-resolution optical access.|
|Karl Deisseroth (2005 Pioneer and 2012 Transformative Researcher) and Xiaoliang Sunney Xie (2004 and 2013 Pioneer and 2009 and 2010 Transformative Researcher) win the prestigious Albany Prize. Dr. Desisseroth is honored for his role in developing optogenetics. Dr. Xie is recognized for his pioneering work in single-molecule biophysical chemistry and its application to biology.|
|Martin Blaser (2010 Transformative Researcher) named in "The 100 Most Influential People" in Time magazine.|
|Save the date for the 2015 High-Risk, High-Reward Research Symposium on December 7-9 at Natcher Conference Center, NIH, Bethesda, MD!|